A Study of SNOT 22 Scores in Adults with no Sinonasal Disease

Abstract: Objective: To identify a normal SNOT-22 score in subjects not known to be suffering from rhino-sinusitis in India.Study design: Analysis of SNOT 22 scores in participants with no sinonasal disease.Setting: Tertiary care hospital in Central India.Participants: 230 participants from medical institution.Results: Results were obtained from 97 men and 133 women with a mean age of 21 (range 18-24). SNOT scores ranged from 0–35 with a mean score of 8.09. The mode was 0 and the median score 7.Conclusion: Due to the skewed nature of the data, the median score (7) is taken as the normal SNOT 22 score. It is recommended that in a clinical situation a SNOT 22 score of 7 be used as a guide for ''normal'', and that caution be exercised when suggesting treatment to patients with a score below 7. It appears feasible that this test be applied pre and post operatively for appropriate selection and judging the outcome respectively

Sino-Nasal Outcome Test-22: Translation, Cross-cultural Adaptation, and Validation in Local Language

Introduction Quality of life questionnaires have been increasingly used in clinical studies to help estimate the magnitude of problem. Sino-Nasal Outcome Test -22 (SNOT-22) is considered to be a good tool to measure the severity of Sino-Nasal Diseases. As this test is in English, it may be difficult for the local population to express their symptoms correctly. Therefore we have translated and validated the SNOT- 22 test in local Indian language, Marathi. Materials and Methods An early Indian ( Marathi ) version of the SNOT 22 questionnaire was prepared. This was a prospective study,where forty patients with Sino-nasal Diseases confirmed on DNE & CT(PNS) filled the questionnaire. This was repeated after a period of 14 days to retest. For validation the questionnaire was also filled by healthy individuals. Results The mean SNOT-22 score ± SD was 50.17 ± 18.65 (range 10–93) in the initial test, and 49.61 ± 18.40 (range 21–91) in retest in the study group. Cronbach’s alpha was 0.835 and 0.837 at the initial and retest examination respectively, both values were suggesting a good internal consistency. The mean SNOT-22 score ± SD was 13 ± 11.68 in the control group and 49.61 ± 18.40 (range 21–91) in the sino-nasal disease group and proved by Mann- Whitney U test. Conclusion The Marathi SNOT-22 is a valid instrument to assess the symptomatology of patients of Sino-nasal Diseases in Maharashtra

Sino-Nasal Outcome Test-22: Translation, Cross-cultural Adaptation, and Validation in Local Language

Introduction Quality of life questionnaires have been increasingly used in clinical studies to help estimate the magnitude of problem. Sino-Nasal Outcome Test -22 (SNOT-22) is considered to be a good tool to measure the severity of Sino-Nasal Diseases. As this test is in English, it may be difficult for the local population to express their symptoms correctly. Therefore we have translated and validated the SNOT- 22 test in local Indian language, Marathi. Materials and Methods An early Indian ( Marathi ) version of the SNOT 22 questionnaire was prepared. This was a prospective study,where forty patients with Sino-nasal Diseases confirmed on DNE & CT(PNS) filled the questionnaire. This was repeated after a period of 14 days to retest. For validation the questionnaire was also filled by healthy individuals. Results The mean SNOT-22 score ± SD was 50.17 ± 18.65 (range 10–93) in the initial test, and 49.61 ± 18.40 (range 21–91) in retest in the study group. Cronbach’s alpha was 0.835 and 0.837 at the initial and retest examination respectively, both values were suggesting a good internal consistency. The mean SNOT-22 score ± SD was 13 ± 11.68 in the control group and 49.61 ± 18.40 (range 21–91) in the sino-nasal disease group and proved by Mann- Whitney U test. Conclusion The Marathi SNOT-22 is a valid instrument to assess the symptomatology of patients of Sino-nasal Diseases in Maharashtra